Tech Company Financing Transactions
Caresyntax Funding Round
Caresyntax secured a $180 million Series C venture capital round on 8/15/2024. Investors included Aescuvest, BlackRock and Lauxera Capital Partners.
Transaction Overview
Company Name
Announced On
8/15/2024
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$180,000,000
Round
Series C
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
800 Boylston St.
Boston, MA 02199
USA
Boston, MA 02199
USA
Phone
Website
Email Address
Overview
At Caresyntax, our core mission is to bridge the variability gap of processes and outcomes in surgery and interventional radiology. We raise the surgical performance bar by empowering clinicians with actionable.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dennis Kogan
Chief Medical Officer
Michael Woods
Chief Technical Officer
Ken Wu
President
Timothy Lantz
VP - Bus. Development
Matthew Krueger
VP - Bus. Development
Björn von Siemens
VP - Bus. Development
Rhonda Wallen
VP - Product Management
Vik Anantha
Browse more venture capital transactions:
Prev: 8/15/2024: Vanilla venture capital transaction
Next: 8/15/2024: Ferretly venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs